Literature DB >> 13292559

Use of reserpine in disturbed psychotic patients.

J A BARSA, N S KLINE.   

Abstract

Entities:  

Keywords:  PSYCHOSES/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh:

Substances:

Year:  1956        PMID: 13292559     DOI: 10.1176/ajp.112.9.684

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  12 in total

1.  [Clinical experiences in reserpine therapy of schizophrenic psychoses with special reference to the relationship somatic findings & EEG].

Authors:  H BAYREUTHER; H RADTKE
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1958

2.  Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.

Authors:  G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-08-13       Impact factor: 8.262

3.  The response of chronically hospitalized, lobotomized patients to treatment with chlorpromazine and reserpine.

Authors:  A A KURLAND; T G WILLIAMS; T E HANLON
Journal:  Psychiatr Q       Date:  1959-10

4.  The psychodynamics of the tranquilizing agents.

Authors:  R J SCHMITT
Journal:  Psychiatr Q       Date:  1957-01

5.  The use of tranquillizers.

Authors:  A R MAY
Journal:  Postgrad Med J       Date:  1957-10       Impact factor: 2.401

6.  [The significance of reserpine-induced parkinsonism for the treatment of schizophrenia].

Authors:  H BAYREUTHER
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1958

Review 7.  The 'atypicality' of antipsychotics: a concept re-examined and re-defined.

Authors:  Gerhard Gründer; Hanns Hippius; Arvid Carlsson
Journal:  Nat Rev Drug Discov       Date:  2009-02-13       Impact factor: 84.694

8.  Reserpine: Problems Associated with the Use of a So-called "Tranquillizing Agent".

Authors:  M Shepherd
Journal:  Proc R Soc Med       Date:  1956-10

9.  Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

Authors:  A Wolkin; E Duncan; M Sanfilipo; S Wieland; T B Cooper; J Rotrosen
Journal:  J Neural Transm Gen Sect       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.